| Jacob Matthew Blackham, | |
|
6982 Coyote Ridge Cir, Herriman, UT 84096-3534 | |
| (435) 262-0806 | |
| Not Available |
| Full Name | Jacob Matthew Blackham |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 6982 Coyote Ridge Cir, Herriman, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154553931 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 7399708-1702 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jacob Matthew Blackham, 6982 Coyote Ridge Cir, Herriman, UT 84096-3534 Ph: () - | Jacob Matthew Blackham, 6982 Coyote Ridge Cir, Herriman, UT 84096-3534 Ph: (435) 262-0806 |
News Archive
Vitamin K, which has been administered to newborns as an injection since it was first recommended by the American Academy of Pediatrics in 1961, is vital for blood to clot normally. Despite it being given as standard medical practice since then, vitamin K-deficient bleeding (VKDB) is being seen more often in newborns than it has in decades.
Some HIV-positive people in Wales are being denied medical treatment for common illnesses, Olwen Williams, a physician specializing in sexually transmitted infections, said recently, BBC News reports. Williams noted that primary care physicians often refer HIV-positive people to hospitals or HIV specialists for common conditions, such as colds.
Previous cancer research has revealed that women are less likely than men to suffer from non-sex specific cancers such as cancer of the colon, pancreas and stomach. Scientists theorized that perhaps this trend was due to a protecting effect created by female hormones, such as estrogen, that help prevent tumors from forming. Now, researchers at the University of Missouri have found evidence suggesting that the male hormone testosterone may actually be a contributing factor in the formation of colon cancer tumors.
Regulus Therapeutics Inc. announced today that it has obtained exclusive rights from the University of Wuerzburg to intellectual property covering methods for modulating microRNA-21. Regulus scientists and collaborators have shown that microRNA-21, (miR-21), is dysregulated in mouse models of cardiac disease and fibrosis, and that antagonizing miR-21 with therapeutic oligonucleotides targeting miR-21 inhibits fibrosis and attenuates cardiac function in such models. Regulus is currently developing a microRNA therapeutic targeting miR-21 as an anti-fibrotic therapy.
› Verified 4 days ago
Dr. Casey Hansen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5627 W 13400 S, Herriman, UT 84096 Phone: 801-307-1909 | |
Dr. Christina Nealson Hackett, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5833 W Muirwood Dr, Herriman, UT 84096 Phone: 801-699-7157 | |
Dr. Patrick Slimak, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5627 W 13400 S, Herriman, UT 84096 Phone: 801-307-1909 Fax: 801-307-1939 | |
Derek Roylance, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4968 W 13400 S, Herriman, UT 84096 Phone: 801-254-6135 | |
Cheyenne Mauldin Cunningham, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5627 W 13400 S, Herriman, UT 84096 Phone: 801-307-1909 Fax: 801-307-1939 | |
Dr. Brian Keith Braegger, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14029 S Ivie Rose Ct, Herriman, UT 84096 Phone: 801-592-2381 |